The
company’s research activities and products are connected
by a common thread focused on the provision of tailored treatments
that work on the body’s own terms to enable doctors combat
numerous diseases and medical conditions. The company has gained
international recognition over the last 20 years for the creation
of inventive medications that improve the quality of life of children
and adults all around the world.
In recent years Ferring has expanded beyond its traditional European
base. It now has offices in over 40 countries employing over 2,700
people, and its treatments are available in more than 70 countries.
Ferring (Pty) Ltd established operations in South Africa in 1996
with a limited portfolio of products. The company has now expanded
its activities into a number of other countries within the region
including Namibia, Botswana, Kenya and Mauritius. Ferring’s
R&D projects complement Ferring’s product portfolio
and will add a new generation of products to some of the company’s
most successful speciality brands.
Ferring is committed to a future where it will continue to provide
new and innovative medicines by utilising existing and acquired
skills and the development of pioneering technologies and, where
necessary, through partnerships with academic institutes and other
companies.
This information is provided for general information only.
It should not be treated as a substitute for the medical advice
of your own doctor or any other medical professional. Any links
accessible from this site are provided in good faith, but we cannot
accept responsibility for their content.
|
